PALI Palisade Bio Inc

Price (delayed)

$1.6

Market cap

$278.83M

P/E Ratio

2.67

Dividend/share

N/A

EPS

$0.6

Enterprise value

$153.61M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 21

Palisade Bio is a late-stage biopharmaceutical company advancing oral therapies that aid patients suffering with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s lead clinical ...

Highlights
The EPS has soared by 115% YoY
Palisade Bio's debt has shrunk by 100% YoY
The net income has plunged by 170% YoY and by 32% from the previous quarter
The equity has decreased by 4.4% from the previous quarter

Key stats

What are the main financial stats of PALI

PALI stock price

How has the Palisade Bio stock price performed over time
Intraday
-5.33%
1 week
-5.33%
1 month
-23.81%
1 year
153%
YTD
-31.91%
QTD
-23.44%

Financial performance

How have Palisade Bio's revenue and profit performed over time
Revenue
$500,000
Gross profit
$500,000
Operating income
-$35.35M
Net income
-$31.94M
Gross margin
100%
Net margin
-6,388.2%
The operating income has plunged by 191% YoY and by 33% from the previous quarter
The net income has plunged by 170% YoY and by 32% from the previous quarter

Price vs fundamentals

How does PALI's price correlate with its fundamentals

Growth

What is Palisade Bio's growth rate over time

Valuation

What is Palisade Bio stock price valuation
P/E
2.67
P/B
2.28
P/S
676.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
307.21
The EPS has soared by 115% YoY
PALI's P/B is 42% above its 5-year quarterly average of 1.7 but 7% below its last 4 quarters average of 2.6
The equity has decreased by 4.4% from the previous quarter

Efficiency

How efficient is Palisade Bio business performance
PALI's ROE has soared by 84% YoY and by 9% from the previous quarter
Palisade Bio's ROA has soared by 76% YoY and by 7% from the previous quarter

Dividends

What is PALI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PALI.

Financial health

How did Palisade Bio financials performed over time
Palisade Bio's total liabilities has increased by 38% YoY but it has decreased by 6% from the previous quarter
The company's total assets fell by 4.5% QoQ
Palisade Bio's debt is 100% lower than its equity
Palisade Bio's debt has shrunk by 100% YoY
PALI's debt to equity has dropped by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.